The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, November 17, 2022
Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc. announced a collaboration and licensing agreement to create conditionally-activated ...
read more
Thursday, November 17, 2022
Takeda announced that the randomized, Phase 3 PhALLCON trial met its primary endpoint, demonstrating that adult patients with newly-diagnosed ...
read more
Tuesday, November 15, 2022
Ashland announced the(FDA Center for Drug Evaluation and Research Office of New Drugs has accepted Ashland Viatel™ bioresorbable mPEG-PDLLA ...
read more
Tuesday, November 15, 2022
The FDA issued a Federal Register notice, Safety and Effectiveness of Certain Naloxone Hydrochloride Drug Products for Nonprescription Use, that may ...
read more
Monday, November 14, 2022
Opiant Pharmaceuticals entered a merger agreement to be acquired by Indivior, a subsidiary of Indivior. Under the terms of the agreement, Indivior ...
read more
Monday, November 14, 2022
AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the ...
read more
Thursday, November 03, 2022
Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, ...
read more
Lannett Company announced that it has received approval from the US Food and Drug Administration (FDA) to manufacture Numbrino®, the company's branded...
read more
Wednesday, October 12, 2022
Illumina announced a strategic research collaboration with AstraZeneca to accelerate drug target discovery by combining their strengths in AI genome ...
read more
Wednesday, October 12, 2022
Agilent Technologies announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom.
read more
Tuesday, October 11, 2022
Ginkgo Bioworks is collaborating with Merck to engineer up to four enzymes for use as biocatalysts in Merck's active pharmaceutical ingredient (API) ...
read more
Eisai announced the appointment of Thomas D. Fagan Jr. as VP of US Alzheimer's Disease Commercial.
read more
Acer Therapeutics Inc., a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-...
read more
Belite Bio, Inc, a San Diego based clinical stage biopharmaceutical drug development company targeting currently untreatable eye diseases, such as ...
read more
Bayer announced that the FDA has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for the oral androgen receptor ...
read more